These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 6393245

  • 1. [Obesity and hypertension. Prevalence, pathogenesis and clinical significance].
    Palumbo G, Schenardi F, Ronchi E, Lucchelli PD.
    Recenti Prog Med; 1984 Sep; 75(9):844-56. PubMed ID: 6393245
    [No Abstract] [Full Text] [Related]

  • 2. Obesity hypertension, salt sensitivity and insulin resistance.
    Rocchini AP.
    Nutr Metab Cardiovasc Dis; 2000 Oct; 10(5):287-94. PubMed ID: 11213538
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of abnormal renal sodium handling in obesity hypertension.
    Hall JE.
    Am J Hypertens; 1997 May; 10(5 Pt 2):49S-55S. PubMed ID: 9160781
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mineralocorticoid receptor activation in obesity hypertension.
    Nagase M, Fujita T.
    Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418
    [Abstract] [Full Text] [Related]

  • 13. Pathways from obesity to hypertension: from the perspective of a vicious triangle.
    Montani JP, Antic V, Yang Z, Dulloo A.
    Int J Obes Relat Metab Disord; 2002 Sep; 26 Suppl 2():S28-38. PubMed ID: 12174326
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Obesity in hypertension: effects on prognosis and treatment.
    Kaplan NM.
    J Hypertens Suppl; 1998 Jan; 16(1):S35-7. PubMed ID: 9534095
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension.
    Baltatzi M, Hatzitolios A, Tziomalos K, Iliadis F, Zamboulis Ch.
    Int J Clin Pract; 2008 Sep; 62(9):1432-40. PubMed ID: 18793378
    [Abstract] [Full Text] [Related]

  • 18. [Hypertension in obesity].
    Skórka B, Chlebus H.
    Pol Tyg Lek; 1984 Apr 09; 39(15):513-7. PubMed ID: 6384963
    [No Abstract] [Full Text] [Related]

  • 19. Insulin and the sympathetic nervous system in the pathophysiology of hypertension.
    Landsberg L.
    Blood Press Suppl; 1996 Apr 09; 1():25-9. PubMed ID: 9162434
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.